Davis R M Inc. disclosed Q1 13F adjustments across several holdings, trimming stakes in MKC, AMETEK, CME Group, and Accenture. In McCormick & Co (MKC), the fund cut its position by 24.1% to 80,883 shares worth about $4.08 million. In AMETEK (AME), it reduced its stake by 1.4% to 307,111 shares, valued at about $65.8 million, with AMETEK representing roughly 1.2% of its portfolio. In CME Group, Davis R M cut exposure by 9.5% to 49,858 shares valued at about $14.7 million. In Accenture (ACN), it reduced holdings by 27.1% to 33,856 shares, worth about $6.71 million. The reporting highlights a broader pattern of portfolio rebalancing, with other institutions also actively adjusting positions in these stocks.